Bioactivity | Ac-macropa is a PSMA-targeted Actinium-225 Conjugate, and can be used for study of prostate cancer[1]. |
Formula | C39H52AcN6O9S |
Molar Mass | 1007.93 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Schatz CA, Moen I, et al. Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer. Clin Cancer Res. 2024;30(11):2531-2544. |